Open AccessJournal Article
Marine natural products as anticancer drugs
TLDR
This review highlights several marine natural products and their synthetic derivatives that are currently undergoing clinical evaluation as anticancer drugs.Abstract:
The chemical and biological diversity of the marine environment is immeasurable and therefore is an extraordinary resource for the discovery of new anticancer drugs. Recent technological and methodologic advances in structure elucidation, organic synthesis, and biological assay have resulted in the isolation and clinical evaluation of various novel anticancer agents. These compounds range in structural class from simple linear peptides, such as dolastatin 10, to complex macrocyclic polyethers, such as halichondrin B; equally as diverse are the molecular modes of action by which these molecules impart their biological activity. This review highlights several marine natural products and their synthetic derivatives that are currently undergoing clinical evaluation as anticancer drugs.read more
Citations
More filters
Journal ArticleDOI
Antiproliferative Activity of Pyracantha and Paullinia Plant Extracts on Aggressive Breast and Hepatocellular Carcinoma Cells
Neha Kaushik,Hyeonyeong Yang,SungRyong Jeong,Nagendra Kumar Kaushik,Pradeep Bhartiya,Linh Nhat Nguyen,Eun Ha Choi,June Hyun Kim +7 more
TL;DR: Results indicate that P. angustifolia and P. cupana offer a promising approach for the development of anticancer agents, however, further detailed research is required to make these plants applicable for therapeutic use.
Book ChapterDOI
Discovery and Computer-Aided Drug Design Studies of the Anticancer Marine Triterpene Sipholanes as Novel P-gp and Brk Modulators
TL;DR: The potential of marine natural products isolated from the Red Sea sponge Callyspongia siphonella for the discovery of novel scaffolds for the control and management of metastatic breast cancer is demonstrated.
Journal ArticleDOI
A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours
Lilian L. Nohara,Sam Ellis,Carola Dreier,Sarah Dada,Iryna Saranchova,K. Choi,Lonna Munro,Cheryl G. Pfeifer,Krysta M. Coyle,Jessica R. Morrice,Paul Ahn,Nicole J. de Voogd,David J. Williams,Pi Yun Cheng,Emmanuel Garrovillas,Raymond J. Andersen,Wilfred A. Jefferies +16 more
TL;DR: In this article , a high-throughput cell-based screening assay was used to identify chemical extracts and unique chemical entities that reverse the downregulation of APM components in cell lines derived from metastatic tumours.
Journal ArticleDOI
Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis
Roberto Catanzaro,Nicola Zerbinati,Umberto Solimene,Gulcin Sagdicoglu Celep,Francesco Marotta,Almagul Kushugulova,Michele Milazzo,C. Tomella,G Bertuccelli,Zhaxybay Zhumadilov +9 more
TL;DR: Clergen significantly inhibited the proliferation of cancer cells in a dose-dependent manner while limiting the cell cycle progression at the G1 phase and significantly inducing apoptosis.
References
More filters
Journal ArticleDOI
Environmental Genome Shotgun Sequencing of the Sargasso Sea
J. Craig Venter,Karin A. Remington,John F. Heidelberg,Aaron L. Halpern,Doug Rusch,Jonathan A. Eisen,Dongying Wu,Ian T. Paulsen,Karen E. Nelson,William C. Nelson,Derrick E. Fouts,Samuel Levy,Anthony H. Knap,Michael W. Lomas,Kenneth H. Nealson,Owen White,Jeremy Peterson,Jeff Hoffman,Rachel Parsons,Holly Baden-Tillson,Cynthia Pfannkoch,Yu-Hui Rogers,Hamilton O. Smith +22 more
TL;DR: Over 1.2 million previously unknown genes represented in these samples, including more than 782 new rhodopsin-like photoreceptors are identified, suggesting substantial oceanic microbial diversity.
Journal ArticleDOI
Natural Products as Sources of New Drugs over the Period 1981−2002
TL;DR: From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well, and in the area of cancer, the percentage of small molecule, new chemical entities that are nonsynthetic has remained at 62% averaged over the whole time frame.
Journal ArticleDOI
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
David J. Newman,Gordon M. Cragg +1 more
TL;DR: There are now significant numbers of very interesting molecules that have come from marine sources, or have been synthesized as a result of knowledge gained from a prototypical compound, that are either in or approaching Phase II/III clinical trials in cancer, analgesia, allergy, and cognitive diseases.
Journal ArticleDOI
Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
TL;DR: This review describes the biochemistry of tubulin, microtubules, and the mitotic spindle and describes the natural and synthetic agents which are known to interact with tubulin.